A² Ventures funds entrepreneurs harnessing software to solve unmet needs in US healthcare. The firm is a dedicated early-stage digital health fund, operating in NY and Tel Aviv, supported by Arkin Capital, strategic institutional investors, and individuals as our LPs. The firm is focused on B2B and B2B2C software-based companies (healthcare IT, tech-centered care delivery, and pharmatech) operating in the US market and looking to lead or co-lead investments in pre-seed to early series A rounds. A² Ventures leverages its deep connections with Arkin Capital’s infrastructure, $2 B AUM and extensive cross-sector exposure, with a particular focus on healthcare and life sciences.